Clinical Trial Update: Nitrocamptothecin in Treating Patients With Advanced or Recurrent Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for nitrocamptothecin in patients with advanced or recurrent colorectal cancer. The current trial status is not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Nitrocamptothecin (nitrocamptothecin)

Snippet

Sponsor: Astex Pharmaceuticals, Inc. | Conditions: Colorectal Cancer | Phase 2 | Status: UNKNOWN